Recombinant multi-species SERPING1/C1 Inactivator protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SERPING1/C1 Inactivator protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]
The Alternative Names of target: C1 Inactivator,C1 Inh,C1 esterase inhibitor,C1-IA,C1-inhibiting factor,C1IN,C1INH,C1INH.,C1Inh,C1NH,C1nh,HAE1,HAE2,Plasma protease C1 inhibitor,SERPING1,Serpin G1,Serping1

Target products collectionGo to SERPING1/C1 Inactivator products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T24211-Ag-1/ GM-Tg-hg-T24211-Ag-2 Human SERPING1/C1 Inactivator protein Human
GM-Tg-rg-T24211-Ag-1/ GM-Tg-rg-T24211-Ag-2 Rat SERPING1/C1 Inactivator protein Rat
GM-Tg-mg-T24211-Ag-1/ GM-Tg-mg-T24211-Ag-2 Mouse SERPING1/C1 Inactivator protein Mouse
GM-Tg-cynog-T24211-Ag-1/ GM-Tg-cynog-T24211-Ag-2 Cynomolgus/Rhesus macaque SERPING1/C1 Inactivator protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T24211-Ag-1/ GM-Tg-felg-T24211-Ag-2 Feline SERPING1/C1 Inactivator protein Feline
GM-Tg-cang-T24211-Ag-1/ GM-Tg-cang-T24211-Ag-2 Canine SERPING1/C1 Inactivator protein Canine
GM-Tg-bovg-T24211-Ag-1/ GM-Tg-bovg-T24211-Ag-2 Bovine SERPING1/C1 Inactivator protein Bovine
GM-Tg-equg-T24211-Ag-1/ GM-Tg-equg-T24211-Ag-2 Equine SERPING1/C1 Inactivator protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T24211-Ag-1/ GM-Tg-hg-T24211-Ag-2; GM-Tg-rg-T24211-Ag-1/ GM-Tg-rg-T24211-Ag-2;
GM-Tg-mg-T24211-Ag-1/ GM-Tg-mg-T24211-Ag-2; GM-Tg-cynog-T24211-Ag-1/ GM-Tg-cynog-T24211-Ag-2;
GM-Tg-felg-T24211-Ag-1/ GM-Tg-felg-T24211-Ag-2; GM-Tg-cang-T24211-Ag-1/ GM-Tg-cang-T24211-Ag-2;
GM-Tg-bovg-T24211-Ag-1/ GM-Tg-bovg-T24211-Ag-2; GM-Tg-equg-T24211-Ag-1/ GM-Tg-equg-T24211-Ag-2
Products Name SERPING1/C1 Inactivator protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SERPING1/C1 Inactivator
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SERPING1/C1 Inactivator protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.